Report period | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
AUPH:US | Aurinia Pharmaceuticals | Common share | - | CA05156V1022 | $6.76 |
Company name | Aurinia Pharmaceuticals |
---|---|
Tags | #pharmacy |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
Business address | #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272 |
Mailing address | #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 |
Website | www.auriniapharma.com |
Information disclosure | www.sec.gov |